Inhibition of group IVA cytosolic phospholipase A2 (cPLA2α) is a potential approach for cancer treatment. Here, the authors report thiazolyl ketone inhibitors of cPLA2α starting from compound ...
How to use virtual reality in simulated practice to teach medicines management to nursing students Education on medication safety is an important part of reducing medication errors. Simulation ...
Impurities in pharmaceuticals are a major concern for drug manufacturers. This article will discuss the importance of ...
Drug-resistant infections are most prevalent ... partnered with Geneva-based non-profit Global Antibiotic Research and Development Partnership, or GARDP, to develop a new class of antibiotics ...
including the development of direct-acting antivirals similar to those used to treat hepatitis C. It also explains how hepatitis B is currently treated and prevented with medications and vaccines. The ...
Recursion is using artificial intelligence and machine learning to accelerate drug research and development. The company benefits from partnerships with major tech and healthcare leaders ...
Dublin, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The "Drug Development Trends in China" report has been added to ResearchAndMarkets.com's offering. China has emerged as a critical player in global drug ...
A breakthrough in understanding how a single-cell parasite ... Carolina-Chapel Hill called the Consortium for Parasitic Drug Development. "We were interested in developing new drugs against ...
with an option to focus on operations management or product development. All students receive in-state tuition when they’re enrolled in Bemidji State University’s online B.S. in project ...
In response, social media companies’ algorithms to detect drug-selling behavior are getting smarter and are aggregating images and emojis, Fuller says. “There is an understanding that seeing ...
Teen drug use continued to fall in 2024, extending a dramatic decline spurred by the COVID-19 pandemic that experts expected would reverse now that the acute phase of the global crisis is well over.
After a detailed review of data from the clinical studies on both drugs, management has decided to focus on its other ongoing pipeline programs. Merck’s decision to discontinue development on ...